Methohexital recalls

The FDA has published 2 recalls involving Methohexital since 2026. The latest was reported on 15 Jul 2026. Most were for potency & assay. QuVa Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 15 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 2 0Aug 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why methohexital is recalled

Potency & Assay2100%

Companies

QuVa Pharma150%
Onesource Specialty Pharma150%

By year

20262100%

Ongoing methohexital recalls

2 active

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Methohexital Sodium, 100 mg/ (10 mg/mL), Total Volume recalled	QuVa Pharma	Potency & Assay	Nationwide
15 Jul 2026Drug	CLASS II	Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial recalledMethohexital Sodium	Onesource Specialty Pharma	Potency & Assay	Nationwide

All methohexital recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
15 Jul 2026Drug	CLASS II	Methohexital Sodium, 100 mg/ (10 mg/mL), Total Volume recalled	QuVa Pharma	Potency & Assay	Nationwide
15 Jul 2026Drug	CLASS II	Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial recalledMethohexital Sodium	Onesource Specialty Pharma	Potency & Assay	Nationwide

Should you stop taking Methohexital?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.